HuGE Literature Finder
Records
1
-
5
Microinsertions in PRKACA cause activation of the protein kinase A pathway in cardiac myxoma. The Journal of pathology 2017 Mar . Tseng I-Ching, Huang Wei-Ju, Jhuang Yu-Ling, Chang Ya-Yun, Hsu Hung-Pin, Jeng Yung-Mi |
Identification of a novel mutation of the PRKAR1A gene in a patient with Carney complex with significant osteoporosis and recurrent fractures. Hormones (Athens, Greece) 2016 Jan 15 (1): 129-35. Papanastasiou Labrini, Fountoulakis Stelios, Voulgaris Nikos, Kounadi Theodora, Choreftaki Theodosia, Kostopoulou Akrivi, Zografos George, Lyssikatos Charalampos, Stratakis Constantine A, Piaditis Geor |
Not all glucocorticoid-induced obesity is the same: differences in adiposity among various diagnostic groups of Cushing syndrome. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2014 Nov 46 (12): 897-903. London E, Lodish M, Keil M, Lyssikatos C, de la Luz Sierra M, Nesterova M, Stratakis C |
Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications. The Journal of clinical endocrinology and metabolism 2014 Feb 99 (2): E303-10. London Edra, Rothenbuhler Anya, Lodish Maya, Gourgari Evgenia, Keil Meg, Lyssikatos Charalampos, de la Luz Sierra Maria, Patronas Nicolas, Nesterova Maria, Stratakis Constantine |
Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. European journal of endocrinology / European Federation of Endocrine Societies 2009 Jul 161 (1): 153-61. Bimpaki Eirini I, Nesterova Maria, Stratakis Constantine |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: